Literature DB >> 11118063

Modulation of tumor angiogenesis by stem cell factor.

W Zhang1, G Stoica, S I Tasca, K A Kelly, C J Meininger.   

Abstract

Mast cells accumulate within solid tumors and can release many angiogenic factors, suggesting that they may modulate vascularization of tumors. Stem cell factor (SCF) stimulates mast cell migration, proliferation, and degranulation and therefore may influence mast cell behavior within tumors. We investigated the contribution of SCF to tumor angiogenesis by manipulating its level in mammary tumors. Sense or antisense cDNA fragments of rat SCF were ligated into an episomal expression vector. Ethylnitrosourea-induced rat mammary tumor cell lines were transfected with vector containing either control (no insert, C-P), sense (S-P), or antisense (AS-P) SCF DNA. The functional nature of the transfectants was confirmed by measuring SCF in cell lysates and conditioned media. Immunohistochemical analysis of the tumors induced in Berlin-Druckrey rats by these transfected cells demonstrated that mast cell number and microvascular density were significantly higher in S-P tumors and significantly lower in AS-P tumors, compared with C-P tumors. The expression of von Willebrand factor, an endothelial cell marker, showed a similar pattern. AS-P tumors were significantly smaller than either C-P or S-P tumors. These data suggest that SCF modulates tumor growth and angiogenesis via the involvement of mast cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11118063

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

Review 1.  Angiogenesis in hematologic malignancies and its clinical implications.

Authors:  Renchi Yang; Zhong Chao Han
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

2.  Participation of mast cells in angiogenesis in the border zone of myocardial infarction in rats.

Authors:  Takayoshi Yamaki; Masumi Iwai-Takano; Hiroyuki Yaoita; Kazuei Ogawa; Hiroko Tajima; Yasuchika Takeishi; Yukio Maruyama
Journal:  J Med Ultrason (2001)       Date:  2009-08-15       Impact factor: 1.314

3.  Immunohistochemical expression of CD117 and vascular endothelial growth factor in retinoblastoma: possible targets of new therapies.

Authors:  Nermeen S Youssef; Azza M Said
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

4.  Stem cell factor improves lung recovery in rats following neonatal hyperoxia-induced lung injury.

Authors:  Luis F Miranda; Claudia O Rodrigues; Shalini Ramachandran; Eneida Torres; Jian Huang; Jammie Klim; Dorothy Hehre; Ian McNiece; Joshua M Hare; Cleide Y Suguihara; Karen C Young
Journal:  Pediatr Res       Date:  2013-10-23       Impact factor: 3.756

5.  Anti-Müllerian hormone inhibits proliferation and induces apoptosis in epithelial ovarian cancer cells by regulating the cell cycle and decreasing the secretion of stem cell factor.

Authors:  Tiansong Zhang; Linhao Deng; Qian Xiong; Shujun Su; Jian Gu
Journal:  Oncol Lett       Date:  2018-06-18       Impact factor: 2.967

Review 6.  Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation.

Authors:  Steven Maltby; Khashayarsha Khazaie; Kelly M McNagny
Journal:  Biochim Biophys Acta       Date:  2009-02-21

7.  Effect of coadministration of ketoconazole, a strong CYP3A4 inhibitor, on pharmacokinetics and tolerability of motesanib diphosphate (AMG 706) in patients with advanced solid tumors.

Authors:  Patricia Lorusso; Elisabeth I Heath; Jesse McGreivy; Yu-Nien Sun; Rebeca Melara; Lucy Yan; Lisa Malburg; Megan Ingram; Jeffrey Wiezorek; Li Chen; Mary Jo Pilat
Journal:  Invest New Drugs       Date:  2008-06-24       Impact factor: 3.850

8.  Expression of C-kit in retinoblastoma: a potential therapeutic target.

Authors:  Robert J Barry; Letícia R de Moura; Jean-Claude Marshall; Bruno F Fernandes; Maria Eugenia Orellana; Emilia Antecka; Claudia Martins; Miguel N Burnier
Journal:  Br J Ophthalmol       Date:  2007-06-25       Impact factor: 4.638

9.  Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy.

Authors:  John M L Ebos; Christina R Lee; James G Christensen; Anthony J Mutsaers; Robert S Kerbel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-17       Impact factor: 11.205

Review 10.  Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy.

Authors:  John M L Ebos; Christina R Lee; Robert S Kerbel
Journal:  Clin Cancer Res       Date:  2009-08-11       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.